Shandong Xinhua Pharmaceutical has obtained the registration certificate for concentrated solutions of sodium, potassium, magnesium, and calcium for injections.
Xinhua Pharmaceutical (000756.SZ) announced that the company has received the "Drug Registration Certificate" for the concentrated solution of sodium, potassium, magnesium, and calcium for injection approved and issued by the National Medical Products Administration. This product is used for electrolyte supplementation when infusing solutions containing concentrated glucose or amino acids through central venous infusion, to maintain electrolyte dynamic balance in adult patients.
Shandong Xinhua Pharmaceutical (000756.SZ) announced that the company has received the "Drug Registration Certificate" for the concentrated solution of sodium-potassium-magnesium-calcium injection approved and issued by the National Medical Products Administration. This product is used for electrolyte supplementation when administering solutions containing concentrated glucose or amino acids through central venous infusion to maintain electrolyte dynamic balance in adult patients.
Related Articles

Chairman Zhong Weiping increased his stake in TAO HEUNG HLDGS (00573) by 325,000 shares at a price of approximately HK$0.3 per share.

QH Technology Holdings Limited reduces its holding in MTT GROUP (02350) by 20 million shares at a price of HK $0.6 per share.

Jushen Logistics Group (001202.SZ) plans to invest no more than 100 million yuan to construct a comprehensive logistics warehouse project.
Chairman Zhong Weiping increased his stake in TAO HEUNG HLDGS (00573) by 325,000 shares at a price of approximately HK$0.3 per share.

QH Technology Holdings Limited reduces its holding in MTT GROUP (02350) by 20 million shares at a price of HK $0.6 per share.

Jushen Logistics Group (001202.SZ) plans to invest no more than 100 million yuan to construct a comprehensive logistics warehouse project.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


